Skip to main content
Journal of Applied Clinical Medical Physics logoLink to Journal of Applied Clinical Medical Physics
. 2007 Feb 28;8(1):108–118. doi: 10.1120/jacmp.v8i1.2380

Development of quality control standards for radiation therapy equipment in Canada

Peter Dunscombe 1,, Harry Johnson 2, Clement Arsenault 3, George Mawko 4, Jean‐Pierre Bissonnette 5, Jan Seuntjens 6
PMCID: PMC5722407  PMID: 17592454

Abstract

Among the essential components of a comprehensive quality assurance program in radiotherapy are the quality control protocols to be used on the equipment and, in particular, the performance objectives and criteria. In the present work, we describe the development of a suite of quality control documents for use across Canada. Following a generic format, we are generating concise, clear standards for the most commonly used equipment in radiotherapy, with the emphasis on performance measures. The final standards of performance are confirmed following cross‐country consultation facilitated by the availability of draft documents on the Canadian Medical Physics web site.

PACS number: 87.53.Xd

Keywords: radiotherapy, quality control, Canada

I. INTRODUCTION

The provision of health care services to Canadians is largely the responsibility of the ten provinces and three territories. Although the services that must be provided free to the population are specified in the federal Canada Health Act, operational and financial aspects of service provision are determined by the provinces and territories. This service delivery structure applies equally to cancer care as it does to other medical services.

The Canadian Association of Provincial Cancer Agencies (CAPCA) is a body that meets regularly to discuss issues of common interest to the organizations responsible for the delivery of cancer care in Canada. A proposal recently accepted by CAPCA was to initiate a process aimed at harmonizing quality assurance activities in radiation treatment programs across the country. This initiative has resulted in a draft document titled Standards for Quality Assurance at Canadian Radiation Treatment Centres. (hereinafter Standards). Practical and essential components of any quality assurance program for radiation therapy are the quality control tests carried out on the increasingly sophisticated equipment used in the planning and delivery of treatment. The draft document referred to appendices, which, when developed, would specify the performance standards to be required of equipment used in the preparation and delivery of radiation therapy to all Canadian cancer patients.

The development of the quality control standards themselves was, appropriately, delegated to the national professional body representing Canadian radiation oncology physicists: the Canadian Organization of Medical Physicists (COMP). In turn, COMP established a Task Group, the members of which are the authors of the present work, to coordinate the generation of the standards documents.

We here describe the philosophy, format, and process adopted by the Task Group, and we refer readers to the web site on which both the approved and draft standards may be reviewed.

II. MATERIALS AND METHODS

A. Documents

The documents upon which the standards are based originated from several sources. Some of the original documents were developed by the Medical Physics Professional Advisory Committee of Cancer Care Ontario and its predecessor, the Ontario Cancer Treatment and Research Foundation. Documents dealing with more recent technology were either specifically commissioned by CAPCA for the purpose of standards development, or, in one case, was based on a recent publication. Also vital to the present project are the many publications relating to quality control and quality assurance in radiotherapy. These include—but are not limited to—recommendations promulgated by the American Association of Physicists in Medicine, (1) The Institute of Physics and Engineering in Medicine, (2) and medical physics compendia.( 3 , 4 )

B. Philosophy and scope

The philosophy behind the development of the Standards documents was that they should focus on the standards themselves and not include descriptions of how the tests are performed. It is assumed that physicists who perform or who supervise the performance of the tests possess an appropriate level of knowledge. Otherwise, the bibliography refers the physicist to the recent literature on the subject. Furthermore, radiation safety has not been specifically included. To do so would require updating the documents each time federal or provincial regulations change, and the Task Group did not feel able to accept this responsibility. However, for completeness, some of the more straightforward tests performed on a daily basis were included.

The Standards documents are intended to be brief and unambiguous. Distribution through a web site facilitates updates as experience with new techniques is gained.

To maintain focus and unambiguity, a generic document format was adopted, with these sections:

  • Introduction—largely generic

  • Performance Objectives and Criteria—generic

  • System Description—custom

  • Acceptance Tests and Commissioning—largely generic

  • Quality Control of Equipment—largely generic

  • Documentation—generic

  • Table of QC Tests—custom entries in a generic format

  • References and Bibliography—custom

C.1 Performance Objectives and Criteria

The generic Performance Objectives and Criteria section includes six classes:

  • Functionality

  • Reproducibility

  • Accuracy

  • Characterisation and Documentation

  • Data Transfer and Validation

  • Completeness

As an example of a generic portion of the documents, Appendix 1 shows the exact wording used in the Performance Objectives and Criteria section. The attempt here, and elsewhere in the generic sections, is to be unambiguous and, where appropriate, prescriptive. The six classes were considered to encompass the range of responses that adequately describe the results of testing. Frequency of testing is also clearly specified, but provides flexibility for operational considerations.

D. Document generation and review

Regardless of whether a source document was commissioned specifically for the development of the Standards or had been generated before this project was initiated, it was sent to a knowledgeable Canadian medical physicist for external review. The reviewer looked at the source document in the light of relevant international recommendations and provided detailed comments on the suggested standards.

Two of the authors of the present work were assigned to each document, one as the primary task group reviewer and one as the secondary reviewer. It was the responsibility of these two members of the group to consider the source document, the external reviewer's comments, and the international literature; to recommend the draft standards; and then to prepare the relevant documentation in the format described above. This task has been simplified for the more recent documents, because the generic format had been decided, and standards could be commissioned to be consistent with that format.

Once the primary and secondary task group reviewers had agreed on their version of the standard, that standard was circulated to whole Task Group for approval. Following this final internal step, the standard was posted on www.medphys.ca for consideration by the Canadian medical physics community at large.

During the next phase, which is ongoing, the comments from physicists “in the field” are being solicited and considered. Comments are fed back into the internal review process, and the standard is modified if required. Comments received so far have ranged from technical to language to typographical. Once the Task Group has reviewed, incorporated, and approved suggested changes, the standards undergo one final formal review by the Canadian Organization of Medical Physicists before national adoption. So far, the national review process has been completed for the first six standards.

III. RESULTS

At the time of writing, standards documents for the following equipment have been approved by COMP:

  • Linear accelerators

  • Conventional simulators

  • Orthovoltage units

  • Cobalt units

  • Multileaf collimators

  • Electronic portal imaging devices

The following draft standards have been posted and are currently under national review:

  • Remote afterloading brachytherapy equipment

  • Major dosimetry equipment

  • CT simulators

  • Prostate brachytherapy equipment

  • SRS/T equipment.

Tables 16 show the six currently approved standards and illustrate the generic format adopted. Notes (not shown for space reasons) accompany each table to clarify the meaning of numerical tolerances and action levels, but these notes do not recommend measurement techniques.

  • Standards currently under development include those for

  • Data management systems

  • Treatment planning systems

  • Intensity‐modulated radiation therapy

Table 1.

Quality control tests for medical linear accelerators (tolerances and action levels are specified in millimeters unless otherwise stated)

Designator Test Performance
Tolerance Action
Daily
DL1 Door interlock/last person out Functional
DL2 Motion interlock Functional
DL3 Couch brakes Functional
DL4 Beam status indicators Functional
DL5 Patient audiovisual monitors Functional
DL6 Room radiation monitors Functional
DL7 Beam interrupt/counters Functional
DL8 Lasers/crosswires 1 2
DL9 Optical distance indicator 1 2
DL10 Optical back pointer 2 3
DL11 Field size indicator 1 2
DL12 Output constancy—photons 2% 3%
DL13 Dynamic wedge factors 1% 2%
DL14 Output constancy—electrons 2% 3%
Monthly
ML1 Emergency off Functional
ML2 Wedge, tray cone interlocks Functional
ML3 Accessories integrity and centering Functional
ML4 Gantry angle readouts 0.5°
ML5 Collimator angle readouts 0.5°
ML6 Couch position readouts 1 2
ML7 Couch isocenter 1 2
ML8 Couch angle 0.5°
ML9 Optical distance indicator 1 2
ML10 Crosswire centering 1 2
ML11 Light/radiation coincidence 1 2
ML12 Field size indicator 1 2
ML13 Relative dosimetry 1% 2%
ML14 Central axis depth dose reproducibility 1 (2%) 2 (3%)
ML15 Beam flatness 2% 3%
ML16 Beam symmetry 2% 3%
ML17 Records Complete
Annually
AL1 Reference dosimetry—TG51 1% 2%
AL2 Relative output factor reproducibility 1% 2%
AL3 Wedge transmission factor reproducibility 1% 2%
AL4 Accessory transmission factor reproducibility 1% 2%
AL5 Output reproducibility vs. gantry angle 1% 2%
AL6 Beam symmetry reproducibility vs. gantry angle 2% 3%
AL7 Monitor chamber linearity 1% 2%
AL8 End monitor effect 0.1 MU 0.2 MU
AL9 Collimator rotation isocenter 1 2
AL10 Gantry rotation isocenter 1 2
AL11 Couch rotation isocenter 1 2
AL12 Coincidence of collimator, gantry, couch axes 1 2
AL13 Coincidence of isocenters 1 2
AL14 Couch deflection 3 5
AL15 Independent quality control review Complete

Table 6.

Quality control tests for electronic portal imaging devices (tolerances and action levels are specified in millimeters unless otherwise stated)

Designator Test Performance
Tolerance Action
Daily
DE1 Mechanical integrity Functional
DE2 Electrical integrity Functional
DE3 Collision interlocks Functional
DE4 Image quality Reproducibility
Monthly
ME1 Positioning in the imaging plane 1 2
ME2 Positioning perpendicular to the imaging plane 10 20
ME3 Image quality Reproducibility
ME4 Artifacts Reproducibility
ME5 Spatial distortion 1 2
ME6 Monitor controls Reproducibility
ME7 Records Complete
Six monthly
SE1 Spatial resolution Reproducibility
SE2 Noise Reproducibility
SE3 On‐screen measurement tools 0.5 1
SE4 Setup verification tools 0.5 (0.5°) 1 (1°)
Annually
AE1 Independent quality control review Complete

Table 2.

Quality control tests for conventional simulators (tolerances and action levels are specified in millimeters unless otherwise stated)

Designator Test Performance
Tolerance Action
Daily
DS1 Door interlock Functional
DS2 Motion interlock Functional
DS3 Beam status indicators Functional
DS4 Emergency off buttons Functional
DS5 Collision avoidance Functional
DS6 Lasers/crosswires 1 2
DS7 Optical distance indicator 1 2
DS8 Crosswires/reticle/block tray 1 2
DS9 Light/radiation coincidence 1 2
DS10 Field size indicators 1 2
Monthly
MS1 Gantry angle readouts 0.5°
MS2 Collimator angle readouts 0.5°
MS3 Couch position readouts 1 2
MS4 Alignment of FAD movement 1 2
MS5 Couch isocenter 2 3
MS6 Couch parallelism 1 2
MS7 Laser/crosswire isocentricity 1 2
MS8 Optical distance indicator 1 2
MS9 Crosswire centering 1 2
MS10 Light/radiation coincidence 1 2
MS11 Field size indicators 1 2
MS12 Records Complete
Six‐monthly
SS1 Lead apron Functional
SS2
kVp
5% 10%
SS3 Reference dosimetry 5% 10%
SS4 Beam quality (HVL) 5% 10%
SS5 Automatic exposure control 5% 10%
SS6 Focal spot Reproducible
SS7 Contrast Reproducible
SS8 Resolution Reproducible
SS9 Fluoroscopic timer 5% 10%
Annually
AS1 Redefine isocenter 1 2
AS2 Couch deflection 3 5
AS3 Alignment of focal spots 0.5 1
AS4 Independent quality control review Complete

Table 3.

Quality control tests for kilovoltage radiotherapy units (tolerances and action levels are specified in millimeters unless otherwise stated)

Designator Test Performance
Tolerance Action
Daily
DK1 Patient monitoring audiovisual devices Functional
DK2 Door closing mechanism and interlock Functional
DK3 Couch movement and brakes Functional
DK4 Unit motions and motion stops Functional
DK5 Interlocks for added filters/kV‐filter choice Functional
DK6 Beam status indicators Functional
DK7 Beam‐off at key‐off test Functional
DK8 Emergency off test Functional
DK9 kV and mA indicators Functional
DK10 Backup timer/monitor unit channel check 1% 2%
DK11 Dosimetric test: output check 3% 5%
Monthly
MK1 Mechanical stability and safety Functional
MK2 Cone selection and competency Functional
MK3 Physical distance indicators 2 3
MK4 Accuracy of head tilt and rotation readouts 1.5°
MK5 Light/x‐ray field coincidence 2 3
MK6 Light field size 2 3
MK7 X‐ray field size indicator 2 3
MK8 X‐ray field uniformity/filter integrity 5% 8%
MK9 Timer and end effect error Characterize ±0.05 min
MK10 Output linearity 1%
MK11 Output reproducibility Characterize <.03 CoV
MK12 Beam quality 10% 15%
MK13 Output calibration verification 2% 3%
MK14 Timer accuracy verification 2% 3%
MK15 Records Complete
Annually
AK1 Reference dosimetry 1% 2%
AK2 Alignment of focal spots 0.5 1
AK3 kVp measurement 5% 10%
AK4 Focal spot size Reproducible
AK5 Independent quality control review Complete

Table 4.

Quality control tests for C60o teletherapy units (tolerances and action levels are specified in millimeters unless otherwise stated)

Designator Test Performance
Tolerance Action
Daily
DCO1 Door interlock/last person out Functional
DCO2 Motion interlock Functional
DCO3 Couch brakes Functional
DCO4 Beam status indicators Functional
DCO5 Patient audiovisual monitors Functional
DCO6 Room radiation monitors Functional
DCO7 Emergency off Functional
DCO8 Beam interrupt/counters Functional
DCO9 Head swivel lock Functional
DCO10 Lasers/crosswires 1 2
DCO11 Optical distance indicator 1 2
DCO12 Optical back pointer 2 3
DCO13 Field size indicator 1 2
Monthly
MCO1 Latching of wedges, trays Functional
MCO2 Wedge interlocks Functional
MCO3 Gantry angle readouts 0.5°
MCO4 Collimator angle readouts 0.5°
MCO5 Couch position readouts 1 2
MCO6 Couch rotation isocenter 2 3
MCO7 Optical distance indicator 1 2
MCO8 Crosswire centering 1 2
MCO9 Light/Radiation coincidence 2 3
MCO10 Field size indicator 1 2
MCO11 Relative dosimetry 1% 2%
MCO12 Shutter error Reproducible
MCO13 Beam symmetry (source position) 2% 3%
MCO14 Records Complete
Annually
ACO1 Reference dosimetry 1% 2%
ACO2 Relative output factor reproducibility 1% 2%
ACO3 Central axis depth dose reproducibility 1% 2%
ACO4 Wedge transmission factor reproducibility 1% 2%
ACO5 Accessory transmission factor reproducibility 1% 2%
ACO6 Output reproducibility vs. gantry angle 1% 2%
ACO7 Beam symmetry reproducibility vs. gantry angle 2% 3%
ACO8 Timer linearity 1% 2%
ACO9 Shutter error 0.03 min. 0.05 min.
ACO10 Collimator rotation isocenter 2 3
ACO11 Gantry rotation isocenter 2 3
ACO12 Couch rotation isocenter 2 3
ACO13 Coincidence of collimator, gantry, couch axes 2 3
ACO14 Coincidence of isocenters 2 3
ACO15 Couch deflection 3 5
ACO16 Independent quality control review Complete

Table 5.

Quality control tests for multileaf collimators (tolerances and action levels are specified in millimeters unless otherwise stated)

Designator Test Performance
Tolerance Action
Patient‐specific
PM1 Verification of transferred data vs. printed template 1 2
PM2 Daily verification of correct data Reproducibility
PM3 Verification of record and verify programming Reproducibility
Monthly
MM1 Digitizer check (if used) Functional
MM2 Light and radiation field coincidence 1 2
MM3 Leaf positions for standard field template 1 2
MM4 Electron field interlocks Functional
MM5 a Leaf alignment 1
MM6 Records Complete
Yearly
AM1 Leaf transmission (all energies) Reproducibility
AM2 Leakage between leaves (all energies) Reproducibility
AM3 a Transmission through abutting leaves Reproducibility
AM4 Stability with gantry rotation Reproducibility
AM5 Alignment with jaws 1
AM6 Independent quality control review Complete
a

May not apply to all designs.

These latter standards will be posted as they become available. The interested reader is directed to www.medphys.ca to review the complete results of the project to date.

IV. DISCUSSION AND CONCLUSIONS

This project has achieved its objectives to date. The largely generic format of the Standards has aided clarity of interpretation and expedited development of the documents—particularly the later documents, which could be composed to fit the format. At some stage in the future, if it is deemed desirable, all the available documents could easily be consolidated into one because so much of the content is generic.

Posting the drafts on an easily accessible web site facilitates feedback and constitutes a method for obtaining a national consensus on the standards. The medical physics community can consider not only the objectives and criteria of the tests, but also the resource implications of adopting the standards. Furthermore, standards approved at this time may easily be updated as new knowledge and equipment become available. Updates can be disseminated almost instantaneously.

The structure of health care delivery in Canada is not conducive to the development of nationally legislated quality control standards, and such legislation is unlikely to be passed in this case. However, once approved and adopted, the standards discussed here may well form an easily monitored component of licensing and accreditation activities applied to cancer treatment facilities.

Objectives and criteria for the evaluation of the performance of radiotherapy equipment fall into several categories:

  1. Functionality. Equipment systems and sub‐systems for which the criterion of performance is “Functional” are either working correctly or not. Such systems are commonly associated with the safety features of the equipment or installation. Operating a facility which has failed a test of functionality has the potential to expose patients and staff to hazardous conditions.

  2. Reproducibility. The results of routine quality control tests, for which reproducibility is the criterion, are assessed against the results obtained at installation from the accepted unit. Tolerances and action levels may be set for parameters that can be quantified.

  3. Accuracy. Accuracy is the deviation of the measured value of a parameter from its expected or defined value. An example is template positional accuracy.

  4. Characterisation and documentation. In some cases it is necessary to make measurements to characterise the performance of a piece of equipment before it can be used clinically. An example is the measurement of the ion collection efficiency of an ionization chamber.

  5. Data transfer and validation. Many systems in use in radiation therapy, and elsewhere, rely heavily upon the appropriate data, such as prescription point and wedge orientation, being input and accurately transmitted through the systems. This category of test is intended to confirm that these processes, involving both humans and machines, are being correctly performed.

  6. Completeness. The use of this term is restricted to the periodic review of quality control procedures, analysis and documentation.

For quantities that can be measured, tolerance and action levels may be defined.

  1. Tolerance Level. For a performance parameter that can be measured, a tolerance level is defined. If the difference between the measured value and its expected or defined value is at or below the stated tolerance level then no further action is required as regards that performance parameter.

  2. Action Level. If the difference between the measured value and its expected or defined value exceeds the action level then a response is required immediately. The ideal response is to bring the system back to a state of functioning that meets all tolerance levels. If this is not immediately possible, then the use of the equipment must be restricted to clinical situations in which the identified inadequate performance is of no or acceptable and understood clinical significance. The decision concerning the most appropriate response is made by the supervising physicist in conjunction with the users of the equipment and others as appropriate. If the difference between the measured value and its expected or defined value lies between the tolerance and action levels, several courses of action are open. For a problem that is easily and quickly rectifiable, remedial action should be taken at once. An alternative course of action is to delay remedial action until the next scheduled maintenance period. Finally, the decision may be made to monitor the performance of the parameter in question over a period of time and to postpone a decision until the behavior of the parameter is confirmed. Once again, this will be a decision made by the supervising physicist in consultation with the users of the equipment and others as appropriate.

Documentation of equipment performance is essential and is discussed later. However, at the conclusion of a series of quality control tests it is essential to inform the users of the equipment of its status. If performance is within tolerance verbal communication with the users is sufficient. If one or more parameters fail to meet Action Level criteria, and immediate remedial action is not possible, then the users of the equipment must be informed in writing of the conditions under which the equipment may be used. Compliance with Action Levels but failure to meet Tolerance Levels for one or more parameters may be communicated verbally or in writing depending on the parameters and personnel involved. The judgment of those involved will be required to make this decision.

REFERENCES

  • 1. Kutcher GJ, Coia L, Gillin M, et al. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys. 1994; 21 (4): 581–618. [DOI] [PubMed] [Google Scholar]
  • 2. Mayles WPM, Lake RA, McKenzie AL, et al., editors. Physics aspects of quality control in radiotherapy. York (United Kingdom): Institute of Physics and Engineering in Medicine; 1999. 286 p. [Google Scholar]
  • 3. van Dyk J, editor. The modern technology of radiation oncology. Madison (WI): Medical Physics Publishing; 1999. 1072 p. [Google Scholar]
  • 4. Podgorsak EB, editor. Review of radiation oncology physics: a handbook for teachers and students. Vienna (Austria): Educational Reports Series, International Atomic Energy Agency; 2003. 696 p. [Google Scholar]

Articles from Journal of Applied Clinical Medical Physics are provided here courtesy of Wiley

RESOURCES